Blood-brain barrier role in Alzheimer’s patients revealed by tissue model
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
List view / Grid view
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
New research into sex-based differences of Parkinson's disease could lead to new treatments.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
Imaging methods are used by scientists to identify therapeutic targets and improve drug efficacy. This article lists five of the latest developments for imaging techniques.
Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice
Scientists have found a way to target and knock out a protein which is widely involved in pancreatic cancer cell growth, survival and invasion.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.
Researchers have discovered a new combination therapy to treat drug-resistant acute lymphoblastic leukaemia, tested in pre-clinical trials.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation which could inform the development of new therapies.
Newly developed HDO-antimiR could lead to new ways to treat diseases which are caused by malfunctioning miRNAs.
Scientists have shown that an omega-6 polyunsaturated fatty acid could halt the progression of atherosclerosis, a leading cause of heart disease.
Using human data, a new study has examined how Cryptococcus genes impact patients with Cryptococcus Neoformans.